Ranibizumab
About Ranibizumab
Ranibizumab is a type of anti-angiogenic that is used in the treatment of wet kind of age related macular degeneration (AMD) that doesn't allow you to see staright ahead. It is also used in treatment of macular edema, diabetic macular edema, diabetic retinopathy.
You should consult your doctor before taking Ranibizumab if you are allergic to it or any of its ingredients, taking any other medicine or supplements, have an infection around your eyes, are pregnant or plan on becoming pregnant, or are breastfeeding. Also, you should not drive after taking Ranibizumab.
The side effects you may experience after taking Ranibizumab includes headache, teary eyes, nausea, itchy eyes, eye redness, eye pain, changes in vision, swelling of eye or eyelids, difficulty in speech, shortness of breath, chest pain. You should immediately see a doctor if the symptoms are severe or if they persist for long.
Ranibizumab is available only as a liqiud solution. It should always be administered by a doctor, usually once in every month, and the treatment should continue as long as prescribed by the doctor.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
What are the uses of Ranibizumab
Wet Form Of Age-Related Macular Degeneration
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
What are the side effects of Ranibizumab ?
Conjunctival Hemorrhage
Eye Inflammation
Increased Intraocular Pressure
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
Key highlights of Ranibizumab
Is It safe with alcohol?
Interaction with alcohol is unknown. Please consult your doctor.
Are there any pregnancy warnings?
Razumab 2.3mg injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.Are there any breast-feeding warnings?
Razumab 2.3mg injection is probably safe to use during breastfeeding. Please consult your doctor.
Is it safe to drive while on this medicine?
Patients may experience temporary visual disturbances and they should avoid driving or operating machinery.
Does this affect kidney function?
There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.
Does this affect liver function?
There is no data available. Please consult doctor before consuming the drug.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
What are the dosage instructions?
Are there any missed dose instructions?
If you miss a dose of Ranibizumab, please consult your doctor.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
Medicines containing Ranibizumab
Below is the list of medicines, which contains Ranibizumab as ingredient
- Lucentis 0.5mg Injection
Novartis India Ltd
- Razumab 2.3Mg Injection
Intas Pharmaceuticals Ltd
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
How does this medication work?
This medicine works by binding to the active forms of VEGF-A along with the biologically active VEGF110. Thus the interaction of VEGF-A with its receptors is inhibited, on the surface of endothelial cells. As a result, endothelial cell multiplication is decreased, and, vascular leakage and new blood vessel formation are also prevented.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Ophthalmologist before using this medicine.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.
Table of content
Ask a free question
Get FREE multiple opinions from Doctors